Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | BOLD-100 |
| Synonyms | |
| Therapy Description |
BOLD-100 is a ruthenium-based small molecule therapeutic that inhibits stress-induced overexpression of GRP78 and may induce increased levels of reactive oxygen species and inhibit DNA repair pathways, potentially leading to decreased tumor cell proliferation and reduced tumor growth (PMID: 32947941, PMID: 36077664). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| BOLD-100 | BOLD100|BOLD 100|IT-139|NKP1339|KP1339 | BOLD-100 is a ruthenium-based small molecule therapeutic that inhibits stress-induced overexpression of GRP78 and may induce increased levels of reactive oxygen species and inhibit DNA repair pathways, potentially leading to decreased tumor cell proliferation and reduced tumor growth (PMID: 32947941, PMID: 36077664). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|